Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 8/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CMA1 | P23946 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23877360 | 0.88 | CMA1 (0.37) | NFE2L2FFAR1CMA1 | |
| SCHEMBL21538770 | 0.88 | NFE2L2 (0.37) | NFE2L2FFAR1PDE10A | |
| SCHEMBL23877351 | 0.85 | NFE2L2 (0.40) | NFE2L2 | |
| SCHEMBL23877358 | 0.79 | NFE2L2 (0.37) | NFE2L2 | |
| SCHEMBL19984938 | 0.79 | FFAR1 (0.34) | NFE2L2FFAR1 | |
| SCHEMBL23877362 | 0.78 | NFE2L2 (0.39) | NFE2L2 | |
| SCHEMBL23877357 | 0.78 | NFE2L2 (0.38) | NFE2L2 | |
| SCHEMBL19984939 | 0.77 | FFAR1 (0.38) | NFE2L2FFAR1CMA1 | |
| SCHEMBL19984924 | 0.75 | PIN1 (0.41) | NFE2L2 | |
| SCHEMBL19985039 | 0.74 | NFE2L2 (0.39) | NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | FGF1, MST1, CDC20 | NFE2L2 2365/4885FFAR1 2309/4885CMA1 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.